Prof. Christian Bär – Dr. Shambhabi Chatterjee | Rewinding the Clock on Lung Disease: A Potential New RNA Therapy for Pulmonary Fibrosis
About this episode
Pulmonary fibrosis is a devastating disease in which lung tissue becomes scarred and stiff, making it harder to breathe. The outlook for patients remains poor, with many surviving only a few years after diagnosis. Current treatments can slow the damage, but they cannot reverse it. New research by the team of Prof. Christian Bär and Dr. Shambhabi Chatterjee of Hannover Medical School and their colleagues explore a promising alternative – one that works at the level of our cells’ biological ‘aging clock’.
Original research published by:
Original article:
Summary of the paper: ‘Telomerase modRNA Offers a Novel RNA-Based Approach to Treat Human Pulmonary Fibrosis’, in Aging Cell, doi.org/10.1111/acel.70240
Contact
For further information, you can connect with Dr, Shambhabi Chatterjee at Chatterjee.Shambhabi@mh-hannover.de and Prof. Dr. Christian Bär at baer.christian@mh-hannover.de
Funding
Deutsche Forschungsgemeinschaft (DFG)
Fraunhofer Cluster of Excellence Immune-Mediated Diseases
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
